Lipid peroxidation in mouse models of atherosclerosis

被引:25
作者
Praticò, D
机构
[1] Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S1050-1738(01)00099-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over the past decade, oxidative modification of low-density lipoprotein (LDL) has been implicated in atherogenesis. This hypothesis has been supported indirectly by a number of in vitro and ex-vivo observations demonstrating the pro-atherogenic properties of oxidized LDL, their occurrence in atherosclerotic lesions and some positive results in animal studies with antioxidants. Only recently, however, have small mammalian models (mouse) of atherosclerosis been created by gene manipulation and widely used by investigators to better elucidate this pathogenetic aspect of such a complex disease. Transgenic animal models combined with the availability of more reliable, specific and sensitive markers of in vivo lipid peroxidation have now provided consistent evidence for a direct and functional role of oxidant stress In atherogenesis. The identification of yet unknown initiating event(s) of in vivo oxidant stress will be the challenge for the future. This should finally provide the basis for the development of most effective antioxidant agents that could modulate atherogenesis. (C) 2001, Elsevier Science Inc.
引用
收藏
页码:112 / 116
页数:5
相关论文
共 50 条
[1]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[2]   The role of oxidized lipoproteins in atherogenesis [J].
Berliner, JA ;
Heinecke, JW .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (05) :707-727
[3]   Mouse models of atherosclerosis [J].
Breslow, JL .
SCIENCE, 1996, 272 (5262) :685-688
[5]  
CHILSOM GM, 1999, J BIOL CHEM, V274, P25959
[6]   Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse [J].
Crawford, RS ;
Kirk, EA ;
Rosenfeld, ME ;
LeBoeuf, RC ;
Chait, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1506-1513
[7]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS [J].
CUSHING, SD ;
BERLINER, JA ;
VALENTE, AJ ;
TERRITO, MC ;
NAVAB, M ;
PARHAMI, F ;
GERRITY, R ;
SCHWARTZ, CJ ;
FOGELMAN, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5134-5138
[8]   Antiatherogenic effects of the antioxidant BO-653 in three different animal models [J].
Cynshi, O ;
Kawabe, Y ;
Suzuki, T ;
Takashima, Y ;
Kaise, H ;
Nakamura, M ;
Ohba, Y ;
Kato, Y ;
Tamura, K ;
Hayasaka, A ;
Higashida, A ;
Sakaguchi, H ;
Takeya, M ;
Takahashi, K ;
Inoue, K ;
Noguchi, N ;
Niki, E ;
Kodama, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10123-10128
[9]   Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice [J].
Cyrus, T ;
Witztum, JL ;
Rader, DJ ;
Tangirala, R ;
Fazio, S ;
Linton, MF ;
Funk, CD .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1597-1604
[10]   Biomarkers of free radical damage applications in experimental animals and in humans [J].
De Zwart, LL ;
Meerman, JHN ;
Commandeur, JNM ;
Vermeulen, NPE .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (1-2) :202-226